Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
51
AUB Quote, Financials, Valuation and Earnings
Last price:
$33.38
Seasonality move
:
2.99%
Day range:
$32.26 - $33.43
52-week range:
$22.85 - $44.54
Dividend yield:
4.01%
P/E ratio:
15.25x
P/S ratio:
3.57x
P/B ratio:
1.49x
Volume:
1.2M
Avg. volume:
1.6M
1-year change:
-16.04%
Market cap:
$4.8B
Revenue:
$817.4M
EPS (TTM):
$2.19
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $686.8M | $670.1M | $702.8M | $701.9M | $817.4M | |
| Revenue Growth (YoY) | 2.4% | -2.44% | 4.88% | -0.13% | 16.46% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $226.5M | $234.3M | $248.4M | $266.9M | $303.5M | |
| Other Inc / (Exp) | -- | $87K | -$3K | -$41M | -$6.5M | |
| Operating Expenses | $212M | $233.5M | $259.2M | $272.7M | $282.8M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $186.3M | $318.8M | $280M | $239.9M | $259.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $28.1M | $54.8M | $45.4M | $38.1M | $50.7M | |
| Net Income to Company | $158.2M | $263.9M | $234.5M | $201.8M | $209.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $158.2M | $263.9M | $234.5M | $201.8M | $209.1M | |
| Basic EPS (Cont. Ops) | $1.93 | $3.26 | $2.97 | $2.53 | $2.29 | |
| Diluted EPS (Cont. Ops) | $1.93 | $3.26 | $2.97 | $2.53 | $2.24 | |
| Weighted Average Basic Share | $78.9M | $77.4M | $74.9M | $75M | $86.1M | |
| Weighted Average Diluted Share | $78.9M | $77.4M | $75M | $75M | $87.9M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $284.5M | $359.9M | $356.1M | $583.3M | $788.8M | |
| Revenue (Reported) | $686.8M | $670.1M | $702.8M | $701.9M | $817.4M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $284.5M | $359.9M | $356.1M | $583.3M | $788.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $165.9M | $161.1M | $161.5M | $172.1M | $212.1M | |
| Revenue Growth (YoY) | 1.2% | -2.89% | 0.27% | 6.52% | 23.26% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $63.9M | $62.9M | $66.8M | $69.3M | $83.8M | |
| Other Inc / (Exp) | -- | -- | -$13.4M | $3K | -$102K | |
| Operating Expenses | $53M | $66M | $69.1M | $69.4M | $84.3M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $67.6M | $53M | $42.9M | $59.9M | $61.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $11.4M | $9.3M | $7.3M | $10.1M | $11.7M | |
| Net Income to Company | $56.2M | $43.7M | $35.7M | $49.8M | $49.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $56.2M | $43.7M | $35.7M | $49.8M | $49.8M | |
| Basic EPS (Cont. Ops) | $0.67 | $0.54 | $0.44 | $0.62 | $0.53 | |
| Diluted EPS (Cont. Ops) | $0.67 | $0.54 | $0.44 | $0.62 | $0.52 | |
| Weighted Average Basic Share | $78.9M | $75.5M | $74.8M | $75.2M | $89.2M | |
| Weighted Average Diluted Share | $78.9M | $75.6M | $74.8M | $75.2M | $90.1M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $80.3M | $60.5M | $107.1M | $175M | $183.2M | |
| Revenue (Reported) | $165.9M | $161.1M | $161.5M | $172.1M | $212.1M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $80.3M | $60.5M | $107.1M | $175M | $183.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $688.8M | $665.3M | $705M | $712.4M | $857.4M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $228.5M | $233.3M | $252.2M | $269.5M | $318M | |
| Other Inc / (Exp) | $10.4M | -- | -$13.4M | -$27.6M | -$6.6M | |
| Operating Expenses | $198.6M | $246.5M | $262.3M | $273M | $297.7M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $245.8M | $304.2M | $269.9M | $256.8M | $261.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $38.5M | $52.7M | $43.5M | $40.9M | $52.3M | |
| Net Income to Company | $207.3M | $251.4M | $226.5M | $215.9M | $209.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $207.3M | $251.4M | $226.5M | $215.9M | $209.2M | |
| Basic EPS (Cont. Ops) | $2.52 | $3.12 | $2.87 | $2.72 | $2.21 | |
| Diluted EPS (Cont. Ops) | $2.52 | $3.12 | $2.87 | $2.72 | $2.19 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $320.4M | $340M | $402.7M | $651.2M | $797M | |
| Revenue (Reported) | $688.8M | $665.3M | $705M | $712.4M | $857.4M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $320.4M | $340M | $402.7M | $651.2M | $797M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $165.9M | $161.1M | $161.5M | $172.1M | $212.1M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $63.9M | $62.9M | $66.8M | $69.3M | $83.8M | |
| Other Inc / (Exp) | -- | -- | -$13.4M | $3K | -$102K | |
| Operating Expenses | $53M | $66M | $69.1M | $69.4M | $84.3M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $67.6M | $53M | $42.9M | $59.9M | $61.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $11.4M | $9.3M | $7.3M | $10.1M | $11.7M | |
| Net Income to Company | $56.2M | $43.7M | $35.7M | $49.8M | $49.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $56.2M | $43.7M | $35.7M | $49.8M | $49.8M | |
| Basic EPS (Cont. Ops) | $0.67 | $0.54 | $0.44 | $0.62 | $0.53 | |
| Diluted EPS (Cont. Ops) | $0.67 | $0.54 | $0.44 | $0.62 | $0.52 | |
| Weighted Average Basic Share | $78.9M | $75.5M | $74.8M | $75.2M | $89.2M | |
| Weighted Average Diluted Share | $78.9M | $75.6M | $74.8M | $75.2M | $90.1M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $80.3M | $60.5M | $107.1M | $175M | $183.2M | |
| Revenue (Reported) | $165.9M | $161.1M | $161.5M | $172.1M | $212.1M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $80.3M | $60.5M | $107.1M | $175M | $183.2M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $491.3M | $799.7M | $318.5M | $364.4M | $350.1M | |
| Short Term Investments | $2.5B | $3.5B | $2.7B | $2.2B | $2.4B | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $3B | $4.3B | $3.1B | $2.6B | $2.8B | |
| Property Plant And Equipment | $163.8M | $134.8M | $118.2M | $91M | $112.7M | |
| Long-Term Investments | $3.1B | $4.1B | $3.6B | $3.1B | $3.2B | |
| Goodwill | $935.6M | $935.6M | $925.2M | $925.2M | $1.2B | |
| Other Intangibles | $57.2M | $43.3M | $26.8M | $19.2M | $84.6M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $19.6B | $20.1B | $20.5B | $21.2B | $24.6B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $100M | -- | $1B | $720M | $60M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $350.9M | $117.9M | $1.3B | $920.8M | $116.3M | |
| Long-Term Debt | $489.8M | $388.7M | $389.9M | $391M | $418.3M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $16.9B | $17.4B | $18.1B | $18.6B | $21.4B | |
| Common Stock | $104.3M | $100.3M | $99M | $99.3M | $118.7M | |
| Other Common Equity Adj | $71M | $18.6M | -$418.3M | -$343.3M | -$359.7M | |
| Common Equity | $2.7B | $2.7B | $2.4B | $2.6B | $3.1B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $2.7B | $2.7B | $2.4B | $2.6B | $3.1B | |
| Total Liabilities and Equity | $19.6B | $20.1B | $20.5B | $21.2B | $24.6B | |
| Cash and Short Terms | $3B | $4.3B | $3.1B | $2.6B | $2.8B | |
| Total Debt | $589.8M | $388.7M | $1.4B | $1.1B | $478.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $400.6M | $391.4M | $371.5M | $394.2M | $430.2M | |
| Short Term Investments | $2.7B | $3.2B | $2.3B | $2.2B | $2.5B | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $3.1B | $3.6B | $2.6B | $2.6B | $2.9B | |
| Property Plant And Equipment | $161.5M | $131M | $116.5M | $90.1M | $111.9M | |
| Long-Term Investments | $3.2B | $4B | $3.1B | $3B | $3.3B | |
| Goodwill | $935.6M | $935.6M | $925.2M | $925.2M | $1.2B | |
| Other Intangibles | $53.5M | $40.3M | $24.5M | $17.3M | $79.2M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $19.9B | $19.8B | $20.1B | $21.4B | $24.6B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | $245M | $600M | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $273.5M | $115M | $408.8M | $666.4M | $57M | |
| Long-Term Debt | $290.1M | $389M | $390.2M | $391.3M | $418.7M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $17.1B | $17.3B | $17.7B | $18.8B | $21.4B | |
| Common Stock | $104.7M | $99.8M | $99.2M | $99.6M | $119M | |
| Other Common Equity Adj | $36.5M | -$191.5M | -$361.9M | -$374.3M | -$333.7M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $2.7B | $2.5B | $2.4B | $2.5B | $3.2B | |
| Total Liabilities and Equity | $19.9B | $19.8B | $20.1B | $21.4B | $24.6B | |
| Cash and Short Terms | $3.1B | $3.6B | $2.6B | $2.6B | $2.9B | |
| Total Debt | $290.1M | $389M | $635.2M | $991.3M | $418.7M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $158.2M | $263.9M | $234.5M | $201.8M | $209.1M | |
| Depreciation & Amoritzation | $43.1M | $50.7M | $45.4M | $41M | $35.3M | |
| Stock-Based Compensation | $9.3M | $10.1M | $10.6M | $11.1M | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $231.9M | $337.8M | $419.7M | $278M | $308.5M | |
| Capital Expenditures | $29.6M | $9.4M | $2.9M | $5.1M | $7.4M | |
| Cash Acquisitions | -- | -- | -- | -- | $55M | |
| Cash From Investing | -$1.9B | -$345.4M | -$1.3B | -$603.3M | -$295.7M | |
| Dividends Paid (Ex Special Dividend) | -$84.5M | -$96.2M | -$98.8M | -$103.3M | -$123.9M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $246.9M | -- | -- | -- | |
| Long-Term Debt Repaid | -$619.6M | -$364.7M | -- | -- | -- | |
| Repurchase of Common Stock | -$49.9M | -$125M | -$48.2M | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $1.7B | $316.9M | $375.2M | $383.4M | -$36.8M | |
| Beginning Cash (CF) | $436M | $493.3M | $802.5M | $319.9M | $378.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $57.3M | $309.2M | -$482.6M | $58.2M | -$24.1M | |
| Ending Cash (CF) | $493.3M | $802.5M | $319.9M | $378.1M | $354.1M | |
| Levered Free Cash Flow | $202.3M | $328.4M | $416.8M | $272.9M | $301.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $56.2M | $43.7M | $35.7M | $49.8M | $49.8M | |
| Depreciation & Amoritzation | $11.9M | $12.2M | $9.8M | $9.5M | $9.3M | |
| Stock-Based Compensation | $2.2M | $2.4M | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $84.4M | $111.4M | $62.5M | $57M | $62M | |
| Capital Expenditures | $3.5M | $797K | $1.6M | $2.1M | $2.4M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$437.4M | -$340M | $402.6M | -$214.9M | $9.6M | |
| Dividends Paid (Ex Special Dividend) | -$22.7M | -$24.1M | -$25.4M | -$27M | -$33.5M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$292.1M | -$2.8M | -- | -- | -- | |
| Repurchase of Common Stock | -- | -$25M | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $260.6M | -$177.6M | -$412.9M | $176.4M | $8.4M | |
| Beginning Cash (CF) | $493.3M | $802.5M | $319.9M | $378.1M | $354.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$92.4M | -$406.2M | $52.2M | $18.5M | $80.1M | |
| Ending Cash (CF) | $400.9M | $396.3M | $372.2M | $396.7M | $434.1M | |
| Levered Free Cash Flow | $80.9M | $110.7M | $60.9M | $54.9M | $59.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $207.3M | $251.4M | $226.5M | $215.9M | $209.2M | |
| Depreciation & Amoritzation | $45M | $51.1M | $43.1M | $40.6M | $35.1M | |
| Stock-Based Compensation | $9.2M | $10.3M | -$2.4M | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $265.9M | $364.9M | $370.7M | $272.5M | $313.5M | |
| Capital Expenditures | $29.1M | $6.7M | $3.7M | $5.6M | $7.7M | |
| Cash Acquisitions | -- | -- | -- | -- | $55M | |
| Cash From Investing | -$2.2B | -$248.1M | -$534.8M | -$1.2B | -$71.1M | |
| Dividends Paid (Ex Special Dividend) | -$87.4M | -$97.6M | -$100M | -$104.9M | -$130.4M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$911.7M | -$75.5M | -- | -- | -- | |
| Repurchase of Common Stock | -- | -$150M | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $1.8B | -$121.4M | $139.9M | $972.7M | -$204.9M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$104.1M | -$4.6M | -$24.1M | $24.5M | $37.5M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $236.8M | $358.2M | $367.1M | $266.9M | $305.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $56.2M | $43.7M | $35.7M | $49.8M | $49.8M | |
| Depreciation & Amoritzation | $11.9M | $12.2M | $9.8M | $9.5M | $9.3M | |
| Stock-Based Compensation | $2.2M | $2.4M | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $84.4M | $111.4M | $62.5M | $57M | $62M | |
| Capital Expenditures | $3.5M | $797K | $1.6M | $2.1M | $2.4M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$437.4M | -$340M | $402.6M | -$214.9M | $9.6M | |
| Dividends Paid (Ex Special Dividend) | -$22.7M | -$24.1M | -$25.4M | -$27M | -$33.5M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$292.1M | -$2.8M | -- | -- | -- | |
| Repurchase of Common Stock | -- | -$25M | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $260.6M | -$177.6M | -$412.9M | $176.4M | $8.4M | |
| Beginning Cash (CF) | $493.3M | $802.5M | $319.9M | $378.1M | $354.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$92.4M | -$406.2M | $52.2M | $18.5M | $80.1M | |
| Ending Cash (CF) | $400.9M | $396.3M | $372.2M | $396.7M | $434.1M | |
| Levered Free Cash Flow | $80.9M | $110.7M | $60.9M | $54.9M | $59.6M | |
Get AUB Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
AUB
Sector
P/E ratio
15.25x
12.21x
PEG ratio
5.96x
0.40x
P/B ratio
1.49x
1.11x
Price / LTM sales
3.57x
2.66x
Growth Metrics
AUB
Sector
Revenue growth
23.26%
5.12%
Earnings growth
-16.13%
2.63%
Revenue (5-year growth)
4.04%
5.17%
Earnings forecast
$0.80
$0.61
Profitability
AUB
Sector
Profitability FY 2025
--
$138.7M
Return on invested capital
5.53%
5.21%
Return on assets
0.87%
0.97%
Return on equity
6.93%
9.24%
Earnings Date
Last Earnings Date
Apr
24
Next Earnings Date
Jul
24
Estimated Next Earnings Date
Jul
24
Balance Sheet
AUB
Sector
Total cash
$2.9B
$451.2M
Short term investments
$2.4B
$220.9M
Total assets
$24.6B
$3.8B
Long term debt
$418.7M
$280.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
